November 10, 2020

Factor Bioscience Granted Second U.S. Patent for mRNA Vectorization of TALENs Technology

Factor Bioscience Inc., a Cambridge-based biotechnology company that develops cell-engineering technologies, today announced that the United States Patent and Trademark Office has granted Factor Bioscience U.S. Patent No. 10,829,738 covering methods for producing gene-edited cells using mRNA encoding transcription activator-like effector nucleases (TALENs). This patent is the second Factor has been granted for the mRNA vectorization of TALENs in 2020.